Hirotaka Takasaki
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: October 27, 2024
Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study.
Journal: Medicine
Published: October 19, 2019
Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
Journal: Proteomics. Clinical applications
Published: July 18, 2019
Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer.
Journal: Medicine
Published: March 12, 2019
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study.
Journal: Oncology letters
Published: May 25, 2018
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.
Journal: Asia-Pacific journal of clinical oncology
Published: December 02, 2017
Chronic lymphocytic leukemia/small lymphocytic lymphoma with t (2;18) (p12;q21) accompanied by a cutaneous nodule with histological features of diffuse large B-cell lymphoma.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 07, 2017
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: June 21, 2016
Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
Journal: International journal of laboratory hematology
Published: June 17, 2016
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma.
Journal: Blood cancer journal
Published: December 05, 2015
Last Updated: 09/26/2026